Roche
ROG.SW
#36
Rank
NZ$604.82 B
Marketcap
NZ$753.90
Share price
0.73%
Change (1 day)
51.72%
Change (1 year)

EPS for Roche (ROG.SW)

EPS in 2023: NZ$29.83

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$29.83. In 2023 the company made an earnings per share (EPS) of NZ$29.83 an increase over its 2022 EPS that were of NZ$29.26.

EPS history for Roche from 1998 to 2023

Annual EPS

Year EPS Change
2023NZ$29.831.95%
2022NZ$29.26-6.29%
2021NZ$31.23-5.53%
2020NZ$33.0616.56%
2019NZ$28.3630.3%
2018NZ$21.7620.22%
2017NZ$18.10-5.81%
2016NZ$19.224.62%
2015NZ$18.37-5.13%
2014NZ$19.37-25.05%
2013NZ$25.8421.73%
2012NZ$21.223.82%
2011NZ$20.448.16%
2010NZ$18.9023.72%
2009NZ$15.28-12.31%
2008NZ$17.42-0.34%
2007NZ$17.4832.13%
2006NZ$13.2342.56%
2005NZ$9.28-22.7%
2004NZ$12.00132.85%
2003NZ$5.16-148.68%
2002NZ-$10.59-209.09%
2001NZ$9.71-57.25%
2000NZ$22.7154.06%
1999NZ$14.7431.24%
1998NZ$11.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.18-39.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.23-55.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$3.00-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.45-78.36%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$12.82-57.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$6.26-79.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Abbott Laboratories
ABT
NZ$14.03-52.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.70-23.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.70-67.48%๐Ÿ‡บ๐Ÿ‡ธ USA